RNS Number:4230Y
Libertas Capital Group PLC
15 February 2006


For immediate release                                         15th February 2006

                           LIBERTAS CAPITAL GROUP plc

                  EXPANSION INTO HEDGE FUND ADVISORY BUSINESS


Libertas Capital Group plc (AIM: LBR) ("Libertas Capital" or "the Company"), the
financial services firm, is pleased to announce that it has set up a joint
venture, DNA Advisors Limited ("DNA"), a business offering hedge fund advisory
services. DNA is 70% owned by Libertas Capital and 30% by the two principals of
DNA, John Davies and Lucy Alexander.

John Davies has over twenty five years' experience in his investment banking
career with Rowe and Pitman, Brown Brothers Harriman & Co and Lehman Brothers
where he became Co-Head of Institutional Equity Sales Europe. In 1997 he joined
Credit Lyonnais in London where he was Global Head of Sales and Sales Trading.
In 2001 he co-founded Altius Partners (a specialist hedge fund and advisory
business), and then went on to set up Green Park Investment in 2004. In 2005,
together with Lucy Alexander, he co-founded DNA. John has a degree in Law from
Emmanuel College, Cambridge. As a result of this transaction, John will cease to
be a Non Executive Director of Libertas Capital from today.

Lucy Alexander has over 16 years of experience in European financial markets.
She started her career at Lehman Brothers in European equity sales in 1989 and
subsequently worked at Merrill Lynch and Salomon Brothers in a similar capacity.
In 2000 she moved to Commerzbank where she set up and headed the Italian sales
desk and was also co-head of the hedge fund sales desk. In 2004 Lucy joined
Green Park Investment, raising capital for hedge funds. In 2005 she co-founded
DNA with John Davies. Lucy has a degree in modern languages from Cambridge
University.

In addition to John Davies and Lucy Alexander, the team now comprises Brigitte
Reinert and Michelle Tully on the sales side together with Pryesh Emrith and
Barbara Travani on research. The firm primarily distributes its single manager
hedge funds and private equity products to funds of hedge funds and private
family offices in Europe and the Middle East.

Commenting on the announcement, Jakob Kinde, Executive Chairman of Libertas
Capital, said: "This is an exciting development for Libertas Capital and we are
delighted that we have attracted two well respected and experienced principals
in John Davies and Lucy Alexander. DNA will be an integral part of Libertas
Capital's strategy, offering opportunities for fundraising as well as building
up an annuity income stream. We offer a warm welcome to them both as well as the
rest of the team. As part of this transaction John will be relinquishing his
role as a Non Executive Director and we wish to thank John for his valued
contribution and wise counsel in that role".


For further information please contact:

Libertas Capital Group plc                                   +44 (0)20 7569 9650
Jakob Kinde, Executive Chairman
Henry Okereke, Chief Executive

DNA Advisors Limited
John Davies, Chief Executive                                 +44 (0)20 7569 9691

Shore Capital                                                +44 (0)20 7408 4090
Guy Peters

Grant Thornton                                                +44(0)20 7383 5100
Graeme Thom/ Fiona Reid

Buchanan Communications                                       +44(0)20 7466 5000
Charles Ryland /Mary-Jane Johnson


Notes to Editors

About Libertas Capital Group plc

Libertas Capital is a UK-based financial services firm offering its clients a
full range of dedicated independent Corporate Finance Advisory, Research and
Distribution services.

Corporate Finance services include advice on M&A, public and private fund
raising, private equity encompassing development capital, MBOs and MBIs,
valuation and exit strategy. In the Securities business Libertas Capital offers
research to corporate and institutional clients, via Equity Growth Research and
Libertas Capital Research, over a global distribution network. Libertas Capital
is focused on the small to mid cap market in the UK, Northern Europe, the Nordic
region, the US and Asia where the Group has gained widespread experience and
developed strong relationships.

Libertas Capital concentrates primarily on growth companies across a number of
industry sectors with a particular focus on environmental sciences, natural
resources, technology (software and business services) and medical technology.



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCGUUUAPUPQGMC
Libertas Capital (LSE:LBR)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Libertas Capital Charts.
Libertas Capital (LSE:LBR)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Libertas Capital Charts.